Hematology and Blood Disorders

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +32-28-08-6657

About The Journal Open Access

Hematology and Blood Disorders

Hematology and Blood Disorders is a novel journal which aims to be a quality platform for advancing the Hematology and blood disorder research. The journal through its rapid publication process brings high quality research, reviews, meta-analysis, reports, and perspectives on all disciplines which fall under the scope of the journal.

Hematology and Blood Disorders is specialised in publishing original articles, review articles, case reports, commentaries, perspective articles, image articles, editorials, letter to editors, mini-review, and short communication etc. in all the areas of hematology and blood disorder research.

Hematology and Blood Disorders is an open access journal designed for the wide dissemination of research in the field to the global audience. The journal is focused on the publication of important breakthroughs in the field of blood and blood related disorder research. Researches including haematological studies, molecular genetics, pathophysiology, etiology, epidemiology, prevention, diagnosis and management of blood disorders fall under the wide aspect of the journal.

Hematology and Blood Disorders scopes are but not limited to anemias, leukemias, blood clotting disorders, multiple myeloma, lymphocytic disorders, immune system disorders, blood count disorders, stem cell disorders, transfusion medicine, hematology, thrombocytopenia, thalassemias, Hodgkins lymphoma, Non-Hodgkin’s lymphoma, red cell biology, immunobiology, hemobiology, bone marrow transplantation, acute myeloid leukemia etc.

The journal accepts original research article, review article, short communication, case report, letter-to-the-Editor and Editorials on recent research developments in hematology and blood disorders for publication. Manuscript processing will be done through the Editorial Manager System to ensure quality in the peer review process. The editorial manager provides easy access to the authors to track the process of manuscript evaluation and publication in an automated way.

All the submitted manuscripts undergo peer review done by the experts of concerned field. Approval of at least two independent reviewers and the editor is mandatory for any manuscript to be considered for publication.

Authors can submit manuscripts online at www.scholarscentral.org/submission/hematology-blood-disorders.html or may send the article as an email attachment either to  [email protected]

Please submit your manuscript to
[email protected]

Just Published Articles

Mini Review May 25, 2020

P.25-27

Hematol Blood Disord: 3(1): 25-27

Hypermanganesemia Revisited

Adel Zeglam

Commentary May 25, 2020

P.23-24

Hematol Blood Disord: 3(1): 23-24

Reduction of frequency of pain in clinical trial with association of arginine and hydroxyurea in sickle cell anemia's patients in Brazil

Renata Eleutério

Short Communication May 25, 2020

P.21-22

Hematol Blood Disord: 3(1): 21-22

Future prospects for DLBCL treatment: Combination of WEE1 inhibitors with CHOP and radiation therapy

Tom van Meerten, Mathilde Rikje Willemijn de Jong, Lydia Visser

Editor Note May 04, 2020

P.1-1

Hematol Blood Disord: 3(1): 1-1

Innovations in Hematological research

Ankit Trivedi

DOI:

Market Analysis January 31, 2020

P.1-2

Hematol Blood Disord: 3(1): 1-2

Breakthrough notions in Hematology and Transfusion Medicine: Market Scrutiny

Shimon Slavin